The Management Board of Bioton S.A. with its registered office in Warsaw ("Issuer") informs that today it received a copy of the statement of claim filed by AIS Investment 2 sp. z o.o from the District Court of the 16th Commercial Division in Warsaw ("Court"). in Warsaw ("Plaintiff") against the Issuer for repealing Resolution No. 2 on the consent to the sale transaction of SciGen Ltd with its registered office in Singapore and defining the basic conditions for the transaction taken on June 11, 2018 by the Issuer's Ordinary General Meeting (see report current report No. 12/2018 of June 11, 2018).
The Issuer does not agree with the pleas of the lawsuit and will ask for its rejection.
Legal basis: § 19 para. 1 point 10 of the Regulation of the Minister of Finance of March 29, 2018 regarding current and periodic information published by issuers of securities and conditions for recognizing as equivalent information required by the laws of a non-member state.
Source: company website, investor relations, current and periodic reports.